You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》高視醫療(02407.HK)公開發售超額認購0.52倍 一手中籤率100%
阿思達克 12-09 09:06
內地眼科醫療器械商高視醫療(02407.HK)公布招股結果,每股發售價定為51.4元,香港公開發售部分錄得超額認購約0.52倍。每手100股計,100%中籤率。該股將於下周一(12日)掛牌。聯席保薦人為大摩及海通國際。 公司上市引入兩名基石投資者,包括「無錫視高、無錫高視及中德基金」,以及CL Kiwi,合共認購630.44萬股公司股份,佔緊隨全球發售完成後已發行股份總數約4.26%。 此外,公司上市料淨集資約2.83億元,約38.2%將用於提高公司的研發能力及加速其專利商業化;約29%將用於提高公司的產能及增強其製造能力;約9.5%將用於擴展公司的銷售及營銷;約10.6%將用作公司的營運資金及一般企業用途;及約12.7%將用於償還公司的計息借款。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account